Research summary, original research, 2014

Feasibility of implementation of a "simplified, No-X-Ray, no-lead apron, two-catheter approach" for ablation of supraventricular arrhythmias in children and adults

Stec S, Śledź J, Mazij M, Raś M, Ludwik B, Chrabąszcz M, et al.. Journal of cardiovascular electrophysiology. 2014

Read the original paper

In plain language

In a registry of 188 patients with supraventricular tachycardia, ablation without fluoroscopy was completed in 179, with outcomes and procedure times similar to X-ray-guided ablation, allowing the electrophysiology team to work without lead aprons.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Patients, Electrophysiologists
Size
n = 902 patients
Summary based on
the abstract

What it found

  • Most patients referred for the No-X-Ray approach completed ablation without any fluoroscopy.

    Key figures: 179/188 patients; 9 protocol exceptions

  • Procedure times did not differ between the No-X-Ray and X-ray control groups.

    Key figures: 63 ± 26 vs. 63 ± 29 minutes, P > 0.05

  • Major complications and acute and long-term success rates were similar between groups.

    Key figures: complications 0% vs. 0%; acute success 98% vs. 98%; long-term 93% vs. 94%; P > 0.05

  • Staff stopped wearing lead aprons after the first 10 nonfluoroscopic cases.

    Key figures: after first 10 cases

Limits to keep in mind

Non-randomized registry comparison with a larger X-ray control group; staff radiation dose and musculoskeletal outcomes were not measured, and countries are not stated in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.